Selank / NA-Selank / NA-Selank-Amidate Testing

MW: 751.88 g/molHalf-life: Minutes systemically (peptide); central effects persist longer.

Heptapeptide based on tuftsin; Russian-developed anxiolytic research peptide. Available as plain, N-acetyl, and amidated variants.

Mechanism of action

Synthetic heptapeptide based on the immunomodulator tuftsin, with an added Pro-Gly-Pro stabilization motif. Anxiolytic effects studied in Russian clinical practice; mechanisms include GABA modulation, BDNF expression, and tuftsin-receptor signaling on macrophages.

Sequence & structure

Thr-Lys-Pro-Arg-Pro-Gly-Pro (7 residues) — plus N-acetyl and/or C-amidate variants

Three different commercial variants: plain Selank, N-acetyl Selank, and N-acetyl-amidate Selank. Vials are very frequently mis-labeled between variants.

Research areas

  • Generalized anxiety (approved in Russia as nasal spray)
  • Stress and cognitive performance
  • Immune modulation

What we test on Selank / NA-Selank / NA-Selank-Amidate

RP-HPLC, high-resolution intact-mass LC-MS (essential to distinguish variants), MS/MS sequence.

Standard Cognitive / Nootropic Panel
  • RP-HPLC purity
  • LC-MS/MS identity (modification confirmation)
  • Residual solvents

Common impurities & failure modes

  • Wrong N-terminal modification

    Plain vs. acetylated produces a 42 Da mass difference, easily resolved.

  • Wrong C-terminus (free acid vs. amide)

    1 Da mass difference; requires high-res MS.

  • Sequence deletion at Pro-Gly-Pro

    Proline coupling difficulty.

Related Cognitive / Nootropic peptides